Karen Curran MBA
Karen Curran is a Chief Strategic Officer at Veramed. She has 25+ years in the Biopharma Industry with Clinical Research Organizations, leading global teams across Standards & Innovation, Data Management, Statistics, Statistical Programming and Medical Writing. With a proven ability to successfully develop, manage and grow dynamic global business units, Karen also has market Expertise in providing strategic guidance and developing innovative solutions for biometric processes, including CDISC adoption and implementation, on both large and small pharma and CRO environments.
Karen has extensive CDISC management knowledge and submission experience including the FDA, EMEA and the PMDA alongside an active leadership involvement in the PHUSE organisation for 5+ years and being a member of the CDISC Board of Directors.
Prior to Veramed, Karen held roles as the Vice President, Global Strategic Partnerships at IQVIA, Vice President and General Manager at CSG, and the Vice President of Global Strategic Partnerships at Covance. Karen received her BS in Mathematics from Shippensburg University, and her MBA from Penn State University.